Does competing risk analysis give useful information about endoprosthetic survival in extremity osteosarcoma? - Wikidata - awgldk - TriplyDB

Does competing risk analysis give useful information about endoprosthetic survival in extremity osteosarcoma?

Does competing risk analysis give useful information about endoprosthetic survival in extremity osteosarcoma?

http://www.wikidata.org/entity/Q35050280

about

Editorial: Estimating survivorship in the face of competing risks.Outcome after Reconstruction of the Proximal Tibia--Complications and Competing Risk Analysis.Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis Oncological and surgical outcome after treatment of pelvic sarcomas.Revision Distal Femoral Arthroplasty With the Compress(®) Prosthesis Has a Low Rate of Mechanical Failure at 10 Years CORR Insights(®): Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.Surgical and Functional Outcome after Endoprosthetic Reconstruction in Patients with Osteosarcoma of the Humerus

P2860

Q35158738-301B20E4-7E4D-4F8E-A7C3-7BF882C58681 Q35744908-1F4BBE45-03BD-4492-B4A6-8C133B4A8B32 Q36100899-0A695463-633C-4AE3-8AF3-BE12FADDA5A3 Q36281288-266EF44C-0E9B-49B4-B391-5C15684160DC Q36452669-AA29F13A-6BEE-4C89-A715-EC52ADA66254 Q41681736-141F84A8-749A-4B57-98DE-3D3C9A1C6202 Q58589596-592AAF62-285A-447C-9CD9-391EBF5C9E95

P2860

Does competing risk analysis give useful information about endoprosthetic survival in extremity osteosarcoma?

http://www.wikidata.org/entity/Q35050280

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Does competing risk analysis g ...... val in extremity osteosarcoma?

@ast

Does competing risk analysis g ...... val in extremity osteosarcoma?

@en

type

label

Does competing risk analysis g ...... val in extremity osteosarcoma?

@ast

Does competing risk analysis g ...... val in extremity osteosarcoma?

@en

prefLabel

Does competing risk analysis g ...... val in extremity osteosarcoma?

@ast

Does competing risk analysis g ...... val in extremity osteosarcoma?

@en

P1433

Q35050280-82CCB264-D3D3-46DA-B793-D59FA34016BD

P1476

Q35050280-CFD93EDD-CBB1-4E6D-88D2-5696F0219246

P2093

Q35050280-386AACBD-6F3D-444D-A530-26DFB917ED93

Q35050280-95B4D057-6A93-4200-AFB7-C17D93E9329F

Q35050280-E2997304-7294-48A9-8C9F-63CFE6855CF3

P2860

Q35050280-03A3891E-848C-4065-A0D5-F1B69E32C288

Q35050280-3BEBEAAF-09D4-4CFB-B11E-A1497D2A23EC

Q35050280-43A5DFF9-1D3E-4CCA-A29C-FC4211233CA1

Q35050280-78469C33-E07C-4F3A-94BC-5445E0827403

Q35050280-8716CAD5-114A-41B7-8560-9B61EA01838F

Q35050280-88341880-2925-44B2-A6D4-4B053535A181

Q35050280-89C0167A-D5F0-4AB6-ACAC-01DD814D7C71

Q35050280-91DEF205-8F5D-4977-9197-8E03714CEDB7

Q35050280-B55873CE-3224-402B-8F80-1C2DB4FD9E02

Q35050280-B83EFBB0-830D-4289-8AF2-F7859BE50F0B

P2888

Q35050280-9330F561-B868-4DD2-BBB9-AE7FE5B9CE21

P304

Q35050280-C20DFF07-908B-4465-BAF0-B10683B71E09

P31

Q35050280-B5094758-3BCE-4C98-8B0F-B8B68A457F8C

P356

Q35050280-58BC98CD-B3CB-428D-95EC-995E8415FE01

P407

Q35050280-717F5FA8-5112-4288-BF0F-C2BE00FC4EA9

P433

Q35050280-08012B6F-E924-43B3-B6F9-500E80C9E7F5

P478

Q35050280-F8AF6211-EB73-4A60-B14A-E16D7357D0BC

P50

Q35050280-A84BCE8B-03DE-4011-898C-B79299437E8C

P577

Q35050280-69046940-77C9-4642-90F3-395C4EF23A81

P698

Q35050280-490AF4B9-A0E3-40A4-AC26-15C50CFC5124

P932

Q35050280-BD23AE51-7C1A-4ABA-9687-996BD35A3A67

P356

S11999-014-3703-X

P1433

Clinical Orthopaedics and Related Research

P1476

Does competing risk analysis g ...... val in extremity osteosarcoma?

@en

P2093

Alexandra Kaider

http://www.w3.org/2001/XMLSchema#string

Philipp T Funovics

http://www.w3.org/2001/XMLSchema#string

Reinhard Schuh

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis

Statistical analysis of arthroplasty register data

Cemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants.

Survival of total knee replacement with a megaprosthesis after bone tumor resection.

Tutorial in biostatistics: competing risks and multi-state models.

Modular megaprosthesis for proximal femoral tumors.

International collaboration is feasible in trials for rare conditions: the EURAMOS experience.

Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review.

Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).

Estimating implant survival in the presence of competing risks.

P2888

s11999-014-3703-x

P304

900-906

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11999-014-3703-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

473

http://www.w3.org/2001/XMLSchema#string

P50

Reinhard Windhager

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24867454

http://www.w3.org/2001/XMLSchema#string

P932

4317420

http://www.w3.org/2001/XMLSchema#string